RVL Pharmaceuticals plc Accumulated Other Comprehensive Income
RVL Pharmaceuticals plc had Accumulated Other Comprehensive Income of $1.70 million as of 2021-12-31, per its 10-K filed 2023-03-20.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-03-20
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.70M.
- 2021-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.23M.
- 2021-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.23M.
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.23M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2021-12-31 | $1.70M 10-K · filed 2023-03-20 | |
| 2021-09-30 | -$2.23M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$2.23M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | -$2.23M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$2.23M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$2.23M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | -$2.23M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | -$2.23M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | -$2.23M 8-K · filed 2021-09-08 | |
| 2019-09-30 | -$2.23M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$1.85M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$1.85M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | -$1.85M 10-K · filed 2020-03-19 | -$1.85M 10-K · filed 2019-03-28 |
| 2018-09-30 | -$1.87M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | -$633.15K 8-K · filed 2019-12-20 |